TRX — Tissue Regenix Income Statement
0.000.00%
Last trade - 00:00- £22.13m
- £27.96m
- $28.65m
Annual income statement for Tissue Regenix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | fx Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 16.4 | 19.7 | 24.5 | 26.3 | 28.6 |
| Cost of Revenue | |||||
| Gross Profit | 7.56 | 8.48 | 11.3 | 13 | 13.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 29 | 24.2 | 26.5 | 26.9 | 28.3 |
| Operating Profit | -12.6 | -4.45 | -2.01 | -0.614 | 0.349 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -13.1 | -5.14 | -2.83 | -1.89 | -0.564 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -12.4 | -4.99 | -2.6 | -1.88 | -0.853 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -12.4 | -4.79 | -2.69 | -1.71 | -0.713 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12.4 | -4.79 | -2.69 | -1.71 | -0.713 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.174 | -0.065 | -0.038 | -0.027 | -0.012 |
| Dividends per Share |